FATHMM-XF: accurate prediction of pathogenic point mutations via extended features by Rogers, Mark F. et al.
Genome analysis
FATHMM-XF: accurate prediction of pathogenic
point mutations via extended features
Mark F. Rogers1,*, Hashem A. Shihab2, MatthewMort3,
David N. Cooper3, Tom R. Gaunt2,† and Colin Campbell1,*,†
1Intelligent Systems Laboratory, University of Bristol, Bristol BS8 1UB, UK, 2MRC Integrative Epidemiology Unit
(IEU), University of Bristol, Bristol BS8 2BN, UK and 3Institute of Medical Genetics, Cardiff University, Cardiff
CF14 4XN, UK
*To whom correspondence should be addressed.
†The authors wish it to be known that, in their opinion, the last two authors should be regarded as Joint Last Authors.
Associate Editor: John Hancock
Received on May 31, 2017; revised on August 14, 2017; editorial decision on August 20, 2017; accepted on September 4, 2017
Abstract
Summary: We present FATHMM-XF, a method for predicting pathogenic point mutations in the
human genome. Drawing on an extensive feature set, FATHMM-XF outperforms competitors on
benchmark tests, particularly in non-coding regions where the majority of pathogenic mutations
are likely to be found.
Availability and implementation: The FATHMM-XF web server is available at http://fathmm.bio
compute.org.uk/fathmm-xf/, and as tracks on the Genome Tolerance Browser: http://gtb.biocom
pute.org.uk. Predictions are provided for human genome version GRCh37/hg19. The data used for
this project can be downloaded from: http://fathmm.biocompute.org.uk/fathmm-xf/
Contact: mark.rogers@bristol.ac.uk or c.campbell@bristol.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Many classifiers have been proposed for predicting the impact of
single-nucleotide variants (SNVs) in the human genome (see Liu
et al., 2017). Initially these focused on non-synonymous mutations
in coding regions of the genome, but most documented pathogenic
SNVs come from non-coding regions, so more recent methods make
predictions genome wide (Kircher et al., 2014; Shihab et al., 2015).
CADD (Kircher et al., 2014) has emerged as a standard for predict-
ing pathogenic SNVs, although its performance has been challenged
(Liu et al., 2017). The recent GAVIN method adjusts CADD scores
in a gene-specific manner, achieving greater accuracy than CADD,
whilst assigning distinct Pathogenic and Benign labels that simplify
interpretation (van der Velde et al., 2017).
Here we present FATHMM with an eXtended Feature set
(FATHMM-XF) which yields highly accurate predictions for SNVs
across the entire human genome. FATHMM-XF assigns a confidence
score (a p-score) to every prediction, to simplify interpretation, and
focus analysis on a subset of high-confidence predictions (cautious
classification). In all tests, FATHMM-XF matches or outperforms
competing methods, with its best performance in non-coding re-
gions, where the majority of pathogenic SNVs are likely to be found.
With cautious classification, FATHMM-XF consistently exceeds
94% accuracy on subsets of 80% of the highest-confidence predic-
tions from benchmark test sets.
2 Materials and methods
To build FATHMM-XF we use supervised machine learning with
labeled examples ascribed to pathogenic (positive) or benign (neu-
tral) mutations. We obtain positive examples from the Human Gene
Mutation Database (Stenson et al., 2017) (HGMD), and neutral ex-
amples from the 1000 Genomes Project (The 1000 Genomes Project
Consortium, 2012). We restrict neutral data to SNVs with a global
minor allele frequency 1% and remove any that appear in the
pathogenic dataset. To mitigate potential bias, we filter neutral
examples, selecting only those within 1000 positions of a pathogenic
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mutation (Supplementary Section S2). In addition, we remove sex
chromosomes X and Y to avoid potential biases that might arise
when allosomes are included. Our final training set consists of
156 775 coding examples and 25 720 non-coding. We characterise
SNVs using features from 27 data sets (herein called feature groups)
from ENCODE (The ENCODE Project Consortium, 2012) and
NIH Roadmap Epigenomics (Bernstein et al., 2010) that have
proved informative in other domains (Shihab et al., 2015, 2017b).
We construct four additional feature groups from conservation
scores, the Variant Effect Predictor (McLaren et al., 2016); anno-
tated gene models, and the DNA sequence itself (Supplementary
Section S3). We convert feature groups into kernels to evaluate dif-
ferent combinations and kernel-based models. k-fold cross-
validation is commonly used to evaluate models, but can introduce
bias if, for example, the same gene is represented in both training
and test sets. Instead, we use leave-one-chromosome-out cross-valid-
ation (LOCO-CV): for each fold we set aside one chromosome for
testing and use the remaining chromosomes for training.
We use Platt scaling (Platt, 1999) to assign a p-score to each pre-
diction (the probability that a particular SNV is pathogenic). For
cautious classification, we then establish confidence thresholds to
analyse sub-populations of high-confidence predictions.
3 Results
For non-coding regions, the best model incorporates five feature
groups, achieving 92.3% accuracy in LOCO-CV (Supplementary
Table S6). Briefly, these feature groups encapsulate sequence conser-
vation, proximity to genomic features (e.g. splice sites or transcrip-
tion start sites) and chromatin accessibility. Cautious classification
reaches 99% peak accuracy at a p-score threshold of s ¼ 0:96
(Supplementary Fig. S2). This high-confidence subset of examples
(p  0.96 or  0.04) comprises nearly 40% of test examples, dem-
onstrating that the threshold is not prohibitively restrictive.
Relaxing the threshold enlarges this subset dramatically whilst re-
taining high accuracy: at s ¼ 0:80, we cover 90% of examples with
accuracy over 95% (Supplementary Section S4).
For coding regions, the best model uses six feature groups, reaching
88.0% accuracy (Supplementary Table S8). Again, conservation fea-
tures are most informative, along with proximity to genomic features
and nucleotide sequence features (Supplementary Section S3). Cautious
classification achieves peak accuracy of 98% at s ¼ 0:97
(Supplementary Fig. S2). This highest-confidence subset again comprises
nearly 40% of examples; at s ¼ 0:80, it includes 80% of examples
with accuracy above 94.0%. We use these peak accuracy thresholds
(0.96 for non-coding, 0.97 for coding) in subsequent analyses.
We compared FATHMM-XF with four genome-wide SNV pre-
diction methods: CADD (Kircher et al., 2014), DANN (Quang
et al., 2014), FATHMM-MKL (Shihab et al., 2015) and GAVIN
(van der Velde et al., 2017). When we compared FATHMM-MKL
LOCO-CV test results with competitors evaluated on the same data,
FATHMM-XF achieved the highest accuracy of all, at 93%
(Supplementary Section S5). In coding regions, FATHMM-XF and
its closest competitor, GAVIN, yielded similar accuracy (88 and
89%, respectively). As reported earlier, FATHMM-XF yielded ex-
ceptionally high accuracy in cautious classification on these data,
whilst consistently yielding predictions for nearly 40% of examples.
To evaluate how well FATHMM-XF will generalise, we tested
all methods on test sets we assembled from ClinVar data (Landrum
et al., 2014) (Supplementary Section S5). After removing any
ClinVar examples found in our training sets, the test sets comprised
31 099 non-coding and 62 884 coding SNVs. In non-coding regions,
FATHMM-XF matches or outperforms other methods, reaching
89% accuracy and 0.97 area under the ROC curve (AUC, Table 1,
top). FATHMM-MKL yields comparable accuracy, but tends to
under-perform the new model. GAVIN achieves higher MCC and
PPV scores at the expense of lower accuracy. In cautious classifica-
tion, FATHMM-XF yields exceptionally high scores, covering
30.9% of examples. In coding regions, it reaches 88% accuracy and
0.96 AUC (Table 1, bottom). GAVIN yields nominally higher accur-
acy (and, notably, 26% higher than CADD, upon which it is based),
but at lower MCC and PPV. With cautious classification,
FATHMM-XF again yields exceptional performance, covering
42.4% of examples. FATHMM-XF at its default threshold covers
100% of test examples, as do the other methods tested.
4 Discussion
At default thresholds, FATHMM-XF matches or outperforms com-
peting methods using an eclectic mixture of data sources. Even when
all methods are optimised, FATHMM-XF yields substantially higher
accuracy in all of our tests (Supplementary Figs S7–S10). Under cau-
tious classification, accuracy exceeds 95%, whilst producing predic-
tions for up to 80% of positions genome-wide. While the proposed
classifiers achieve high accuracy, further improvement seems pos-
sible. Notably, all methods exhibit low PPV on non-coding data ex-
cept for FATHMM-XF’s cautious classification. Analysis of these
variants (Supplementary Fig. S1) reveals differences in the propor-
tions of intron and UTR variants represented in the training and test
sets. Hence region-specific models may improve performance in non-
coding regions, just as GAVIN’s gene-specific thresholding improves
accuracy for CADD scores—by up to 26 percentage points in our
tests. We will explore these approaches in future work. The
FATHMM-XF web server for GRCh37/hg19 is available at
fathmm.biocompute.org.uk/fathmm-xf, and as tracks on the Genome
Tolerance Browser (gtb.biocompute.org.uk; Shihab et al., 2017a).
Table 1. FATHMM-XF yields state-of-the-art accuracy on unseen
ClinVar examples in both non-coding regions and coding regions.
Non-coding regions
Method Acc. AUC Sens. Spec. MCC PPV
FATHMM-XF 0.89 0.97 0.95 0.84 0.53 0.36
Cautious (s ¼ 0:96) 0.96 0.99 0.99 0.93 0.87 0.82
FATHMM-MKL 0.88 0.95 0.94 0.82 0.49 0.33
GAVIN 0.87 — 0.82 0.93 0.61 0.52
CADD (v1.3) 0.64 0.95 0.98 0.30 0.18 0.12
DANN 0.61 0.95 0.99 0.23 0.15 0.11
Coding regions Acc. AUC Sens. Spec. MCC PPV
FATHMM-XF 0.88 0.96 0.84 0.92 0.76 0.83
Cautious (s ¼ 0:97) 0.97 0.99 0.94 1.00 0.96 0.99
GAVIN 0.89 — 0.90 0.87 0.74 0.76
FATHMM-MKL 0.80 0.90 0.91 0.70 0.56 0.58
CADD (v1.3) 0.63 0.91 0.98 0.29 0.30 0.38
DANN 0.60 0.89 0.99 0.20 0.25 0.36
Note: (Top) FATHMM-XF yields the highest accuracy on unseen ClinVar
examples for non-coding regions, outperforming its nearest competitor,
FATHMM-MKL. Cautious classification yields exceptionally high scores,
yielding predictions for 31% of examples. (Bottom) FATHMM-XF yields
higher accuracy, AUC, MCC and PPV scores than competitors on unseen
ClinVar examples in coding regions. The lone exception is GAVIN, with
nominally higher accuracy. Cautious classification again achieves extremely
high scores, yielding predictions for more than 42% of test examples.
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